We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Genentech, Tercica Prevail In Suit Against Insmed

Law360 (December 6, 2006, 12:00 AM EST) -- A California jury awarded $7.5 million plus royalties to biotechnology company Genentech Inc. and its licensee, Tercica Inc, after a “clean sweep” verdict that found a rival start-up infringed its patents...
To view the full article, register now.